Showing results 1 to 4 of 4
Issue Date | Title | Author(s) |
---|---|---|
2024-03 | Discovery of N-benzylbenzamide-based allosteric inhibitors of Aurora kinase A | Lee, Hyomin; Kim, Euijung; Hwang, Narae; Yoo, Jesik; Nam, Yunju; Hwang, Injeoung; Park, Jin-Gyeong; Park, Sang-Eun; Chung, Kyung-Sook; Chung, Hwan Won; Song, Chiman; Ji, Mi-Jung; Park, Hyun-Mee; Lee, In-Kyun; Lee, Kyung-Tae; Roh, Eun Joo; Hur, Wooyoung |
2024-01 | Identification of a novel potent CDK inhibitor degrading cyclinK with a superb activity to reverse trastuzumab-resistance in HER2-positive breast cancer in vivo | Kuchukulla, Ratnakar Reddy; Hwang, Injeoung; Kim, Suhn Hyung; Kye, Younghyeon; Park, NaRae; Cha, Heary; Moon, Sojeong; Chung, Hwan Won; Lee, Cheolju; Kong, Gu; Hur, Woo young |
2023-09 | Identification of novel class inhibitors of NSD3 methyltransferase showing a unique, bivalent binding mode in the SET domain | Kim, Sumin; Hwang, Injeoung; Kim, Suhn Hyung; Chung, Hwan Won; Ji, Mi-Jung; Moon, Sojeong; Park, Hyun-Mee; Kong, Gu; Hur, Wooyoung |
2022-09 | Novel 2,6,9-Trisubstituted Purines as Potent CDK Inhibitors Alleviating Trastuzumab-Resistance of HER2-Positive Breast Cancers | Kuchukulla, Ratnakar Reddy; Hwang, Injeoung; Park, Sang Won; Moon, Sojeong; Kim, Suhn Hyung; Kim, Sumin; Chung, Hwan Won; Ji, Mi-Jung; Park, Hyun-Mee; Kong, Gu; Hur, Wooyoung |